Search Results - "SHAW, Lynn C"

Refine Results
  1. 1

    Inflammation in the pathogenesis of microvascular complications in diabetes by Nguyen, Dung V, Shaw, Lynn C, Grant, Maria B

    “…Diabetes and hyperglycemia create a proinflammatory microenvironment that progresses to microvascular complications such as nephropathy, retinopathy, and…”
    Get full text
    Journal Article
  2. 2

    Per2 Mutation Recapitulates the Vascular Phenotype of Diabetes in the Retina and Bone Marrow by BHATWADEKAR, Ashay D, YUANQING YAN, BOULTON, Michael E, GRANT, Maria B, XIAOPING QI, THINSCHMIDT, Jeffrey S, NEU, Matthew B, LI CALZI, Sergio, SHAW, Lynn C, DOMINIGUEZ, James M, BUSIK, Julia V, LEE, Choogon

    Published in Diabetes (New York, N.Y.) (01-01-2013)
    “…In this study, we assessed whether Per2 clock gene-mutant mice exhibit a vascular phenotype similar to diabetes. Per2 (B6.129-Per2(tm1Drw)/J) or wild-type…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Nitric Oxide Cytoskeletal–Induced Alterations Reverse the Endothelial Progenitor Cell Migratory Defect Associated With Diabetes by SEGAL, Mark S, SHAH, Ronak, TRAN-SON-TAY, Roger, GRANT, Maria B, AFZAL, Aqeela, PERRAULT, Cecile M, CHANG, Kyunghee, SCHULER, Anna, BEEM, Elaine, SHAW, Lynn C, CALZI, Sergio Li, HARRISON, Jeffrey K

    Published in Diabetes (New York, N.Y.) (01-01-2006)
    “…Nitric Oxide Cytoskeletal–Induced Alterations Reverse the Endothelial Progenitor Cell Migratory Defect Associated With Diabetes Mark S. Segal 1 , Ronak Shah 1…”
    Get full text
    Journal Article
  5. 5

    EPCs and pathological angiogenesis: When good cells go bad by Calzi, Sergio Li, Neu, Matthew B., Shaw, Lynn C., Kielczewski, Jennifer L., Moldovan, Nicanor I., Grant, Maria B.

    Published in Microvascular research (01-05-2010)
    “…Bone-marrow-derived endothelial progenitor cells (EPCs) contribute to angiogenesis-mediated pathological neovascularization, and recent studies have begun to…”
    Get full text
    Journal Article
  6. 6

    Bone marrow-CNS connections: Implications in the pathogenesis of diabetic retinopathy by Yellowlees Douglas, Jane, Bhatwadekar, Ashay D., Li Calzi, Sergio, Shaw, Lynn C., Carnegie, Debra, Caballero, Sergio, Li, Quihong, Stitt, Alan W., Raizada, Mohan K., Grant, Maria B.

    Published in Progress in retinal and eye research (01-09-2012)
    “…Diabetic retinopathy is the fourth most common cause of blindness in adults. Current therapies, including anti-VEGF therapy, have partial efficacy in arresting…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3 by Jarajapu, Yagna P R, Cai, Jun, Yan, Yuanqing, Li Calzi, Sergio, Kielczewski, Jennifer L, Hu, Ping, Shaw, Lynn C, Firth, Sue M, Chan-Ling, Tailoi, Boulton, Michael E, Baxter, Robert C, Grant, Maria B

    Published in PloS one (06-07-2012)
    “…Previously, we showed that insulin growth factor (IGF)-1 binding protein-3 (IGFBP-3), independent of IGF-1, reduces pathological angiogenesis in a mouse model…”
    Get full text
    Journal Article
  9. 9

    The role of growth factors in the pathogenesis of diabetic retinopathy by Grant, Maria B, Afzal, Aqeela, Spoerri, Polyxenie, Pan, Hao, Shaw, Lynn C, Mames, Robert N

    Published in Expert opinion on investigational drugs (01-10-2004)
    “…Diabetic retinopathy (DR) is the most severe of several ocular complications of diabetes. The earliest clinical signs of DR are microaneurysms and…”
    Get more information
    Journal Article
  10. 10

    Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization by Sengupta, Nilanjana, Afzal, Aqeela, Caballero, Sergio, Chang, Kyung-Hee, Shaw, Lynn C, Pang, Ji-Jing, Bond, Vincent C, Bhutto, Imran, Baba, Takayuki, Lutty, Gerard A, Grant, Maria B

    “…Modulators of angiogenesis typically work in an orchestrated manner. The authors examined the interaction between insulinlike growth factor (IGF)-1, vascular…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Molecular Targeting of Antiangiogenic Factor 16K hPRL Inhibits Oxygen-Induced Retinopathy in Mice by Pan, Hao, Nguyen, Ngoc-Quynh-Nhu, Yoshida, Hiroshi, Bentzien, Frauke, Shaw, Lynn C, Rentier-Delrue, Francoise, Martial, Joseph A, Weiner, Richard, Struman, Ingrid, Grant, Maria B

    “…To examine the ability and mechanism of the 16 kDa N-terminal fragment of human prolactin (16K hPRL) in the inhibition of abnormal retinal neovascularization…”
    Get full text
    Journal Article Web Resource
  14. 14
  15. 15

    Progenitor cell combination normalizes retinal vascular development in the oxygen-induced retinopathy (OIR) model by Li Calzi, Sergio, Shaw, Lynn C, Moldovan, Leni, Shelley, William C, Qi, Xiaoping, Racette, Lyne, Quigley, Judith L, Fortmann, Seth D, Boulton, Michael E, Yoder, Mervin C, Grant, Maria B

    Published in JCI insight (01-11-2019)
    “…Retinopathy of prematurity (ROP) is a disorder of the developing retina of preterm infants. ROP can lead to blindness because of abnormal angiogenesis that is…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Cell-Based Therapies for Diabetic Retinopathy by Shaw, Lynn C., Neu, Matthew B., Grant, Maria B.

    Published in Current diabetes reports (01-08-2011)
    “…Autologous endothelial progenitor cell (EPC) populations represent a novel treatment for therapeutic revascularization and vascular repair for diabetic…”
    Get full text
    Journal Article
  19. 19

    An ocular view of the IGF–IGFBP system by Nguyen, Dung V, Li Calzi, Sergio, Shaw, Lynn C, Kielczewski, Jennifer L, Korah, Hannah E, Grant, Maria B

    Published in Growth hormone & IGF research (01-06-2013)
    “…Abstract IGFs and their binding proteins have been shown to exhibit both protective and deleterious effects in ocular disease. Recent studies have…”
    Get full text
    Journal Article
  20. 20